Stay updated with the latest cyclic-guanosine-monophosphate news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on cyclic-guanosine-monophosphate topics.
Stempeutics will have to meet certain regulatory milestones, he said, as the product would be made in India and sent to Japan In a first of sorts in stem cell therapy, India's Stempeutics has inked an "option licence agreement" with Japan's Medinet, a listed company focussed on regenerative medicine - to take the former's product used in treating chronic limb threatening ischemia (CLTI), to Japan. Japan is a tough regulatory market, BN Manohar, Stempeutics Chief Executive Officer told business ...Read More >
New Delhi: Traffic in central Delhi will be affected on Thursday as the traffic police has issued an advisory due to the Janmashtami and Tazia processions.According to police, the traffic movement in Paharganj is likely to be affected from 1.30pm in view of the shobha yatra for Janmashtami and the Tazia procession.The Janmashtami procession will start from Mandir Shri Banke Bihari Ji in Paharganj's Sangatrasan Bazar and pass through Desh Bandhu Gupta Road, Chuna Mandi, Main Bazar, Munja Chowk an ...Read More >
Cohance Lifesciences will be investing ₹23 crore (₹230 million) in its new Current Good Manufacturing Practice (cGMP) oligonucleotide building block manufacturing facility in Hyderabad. "Oligonucleotides are a fast-emerging therapeutic class, and innovators are seeking integrated, cost-efficient partners with scalable GMP capacity. This facility is a high-impact strategic investment that complements our pilot and scale-up assets, positioning Cohance to deliver with speed, quality and flexibi ...Read More >
Hyderabad: Cohance Lifesciences Limited, backed by PE giant Advent International, is investing Rs 110 crore in its facilities in Hyderabad and New Jersey. This includes $10 million (approx. Rs 87 crore) in expanding its cGMP bioconjugation capabilities at its US-based subsidiary, NJ Bio, and Rs 23 crore in its new cGMP oligonucleotide building block manufacturing facility in Hyderabad.The new facility in Hyderabad, Cohance said, will enable it to take high-value chemistries like modified nucleos ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.